loadpatents
Patent applications and USPTO patent grants for Hamill; Terence G..The latest application filed is for "pharmaceutical compositions for the treatment of pain and other indications".
Patent | Date |
---|---|
Imidazole derivatives useful as modulators of FAAH and as FAAH imaging agents Grant 8,664,253 - Liu , et al. March 4, 2 | 2014-03-04 |
Pharmaceutical Compositions For The Treatment Of Pain And Other Indications App 20130030000 - Chobanian; Harry R. ;   et al. | 2013-01-31 |
Imidazole Derivatives Useful As Modulators Of Faah And As Faah Imaging Agents App 20120115894 - Liu; Ping ;   et al. | 2012-05-10 |
Radiolabeled glycine transporter inhibitors Grant 7,834,031 - Burns , et al. November 16, 2 | 2010-11-16 |
Radiolabeled cannabinoid-1 receptor modulators Grant 7,754,188 - Burns , et al. July 13, 2 | 2010-07-13 |
Radiolabeled Glycine Trasporter Inhibitors App 20090269278 - Burns; H. Donald ;   et al. | 2009-10-29 |
Radiolabeled neurokinin-1 receptor antagonists Grant 7,354,935 - Burns , et al. April 8, 2 | 2008-04-08 |
Substituted amides App 20060115425 - Burns; H. Donald ;   et al. | 2006-06-01 |
Radiolabeled neurokinin-1 receptor antagonists App 20050214204 - Burns, H. Donald ;   et al. | 2005-09-29 |
Radiolabeled neuropeptide Y Y5 receptor antagonists Grant 6,939,966 - Burns , et al. September 6, 2 | 2005-09-06 |
Radiolabeled neuropeptide y y5 receptor antagonists App 20040192705 - Burns, H. Donald ;   et al. | 2004-09-30 |
F-18 radiolabeled neurokinin-1 receptor antagonists Grant 6,241,964 - Burns , et al. June 5, 2 | 2001-06-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.